Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
A crucial issue for antiviral therapy is the fact that all antiviral substances rapidly select for resistance; thus, monitoring and overcoming resistance has become a most important clinical paradigm of antiviral therapy. This calls for cautious use of antiviral drugs and implementation of combination therapies. In parallel, efforts in drug discovery have to be continued to develop compounds with novel mode-of-action and activity against resistant strains. This book reviews the current status of antiviral therapy, from the roads to development of new compounds to their clinical use and cost…mehr
A crucial issue for antiviral therapy is the fact that all antiviral substances rapidly select for resistance; thus, monitoring and overcoming resistance has become a most important clinical paradigm of antiviral therapy. This calls for cautious use of antiviral drugs and implementation of combination therapies. In parallel, efforts in drug discovery have to be continued to develop compounds with novel mode-of-action and activity against resistant strains. This book reviews the current status of antiviral therapy, from the roads to development of new compounds to their clinical use and cost effectiveness. Individual chapters address in more detail all available drug classes and outline new approaches currently under development.
Antiviral Strategies.- Approaches for the Development of Antiviral Compounds: The Case of Hepatitis C Virus.- Antiviral Agents Acting as DNA or RNA Chain Terminators.- Viral Protease Inhibitors.- Anti-Influenza Drugs: The Development of Sialidase Inhibitors.- Other Inhibitors of Viral Enzymes and Functions.- Inhibitors of Viral Entry.- Interferons and Their Use in Persistent Viral Infections.- Nucleic Acids-Based Therapeutics in the Battle Against Pathogenic Viruses.- Antiviral Gene Therapy.- Antiviral Resistance and Impact on Viral Replication Capacity: Evolution of Viruses Under Antiviral Pressure Occurs in Three Phases.- Antiviral Combination Therapy for Treatment of Chronic Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection.- Socio-Economic Impact of Antiviral Intervention.
Antiviral Strategies.- Approaches for the Development of Antiviral Compounds: The Case of Hepatitis C Virus.- Antiviral Agents Acting as DNA or RNA Chain Terminators.- Viral Protease Inhibitors.- Anti-Influenza Drugs: The Development of Sialidase Inhibitors.- Other Inhibitors of Viral Enzymes and Functions.- Inhibitors of Viral Entry.- Interferons and Their Use in Persistent Viral Infections.- Nucleic Acids-Based Therapeutics in the Battle Against Pathogenic Viruses.- Antiviral Gene Therapy.- Antiviral Resistance and Impact on Viral Replication Capacity: Evolution of Viruses Under Antiviral Pressure Occurs in Three Phases.- Antiviral Combination Therapy for Treatment of Chronic Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection.- Socio-Economic Impact of Antiviral Intervention.
Antiviral Strategies.- Approaches for the Development of Antiviral Compounds: The Case of Hepatitis C Virus.- Antiviral Agents Acting as DNA or RNA Chain Terminators.- Viral Protease Inhibitors.- Anti-Influenza Drugs: The Development of Sialidase Inhibitors.- Other Inhibitors of Viral Enzymes and Functions.- Inhibitors of Viral Entry.- Interferons and Their Use in Persistent Viral Infections.- Nucleic Acids-Based Therapeutics in the Battle Against Pathogenic Viruses.- Antiviral Gene Therapy.- Antiviral Resistance and Impact on Viral Replication Capacity: Evolution of Viruses Under Antiviral Pressure Occurs in Three Phases.- Antiviral Combination Therapy for Treatment of Chronic Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection.- Socio-Economic Impact of Antiviral Intervention.
Antiviral Strategies.- Approaches for the Development of Antiviral Compounds: The Case of Hepatitis C Virus.- Antiviral Agents Acting as DNA or RNA Chain Terminators.- Viral Protease Inhibitors.- Anti-Influenza Drugs: The Development of Sialidase Inhibitors.- Other Inhibitors of Viral Enzymes and Functions.- Inhibitors of Viral Entry.- Interferons and Their Use in Persistent Viral Infections.- Nucleic Acids-Based Therapeutics in the Battle Against Pathogenic Viruses.- Antiviral Gene Therapy.- Antiviral Resistance and Impact on Viral Replication Capacity: Evolution of Viruses Under Antiviral Pressure Occurs in Three Phases.- Antiviral Combination Therapy for Treatment of Chronic Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection.- Socio-Economic Impact of Antiviral Intervention.
Rezensionen
Aus den Rezensionen: "Dieses umfassende Werk gibt einen aktuellen und detaillierten Überblick über diverse virale Erreger und deren Therapiemöglichkeiten. Vorgestellt werden die ... Medikamentenklassen und in Entwicklung befindliche Behandlungsansätze." (in: Neurologie Psychiatrie, 2008, Issue 5, S. 51)
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
